The NHS Diabetic Eye Screening (DES) Programme helps prevent sight loss in people with diabetes. Screening can detect diabetic retinopathy early, when treatment is effective at reducing or preventing damage from the condition.
Dr Peter Scanlon
Dr Peter Scanlon is Clinical Director of the NHS Diabetic Eye Screening Programme. With the support and co-operation of colleagues, he helped move screening from limited ad hoc delivery of services to a systematic quality assured programme for all people with diabetes aged 12 and over in England. He is a Senior Research Fellow and Medical Tutor at Harris Manchester College, University of Oxford, and Visiting Professor at the University of Gloucestershire.
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.
Comments and moderation
- Changes ahead for the national screening system 30 September 2021
- What we blogged about in August and September 2021 30 September 2021
- New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021